Eukaryotic Transcription Inhibitors
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 15, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Peter J Harte1, Patricia Ernst2
1Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
No abstract available in PubMed .